Al Malki, Monzr M.
~ 200  results:
Search for persons X
?
1

Phase 1 Trial Investigating the Safety and Tolerability of ..:

Salhotra, Amandeep ; Yang, Dongyun ; Mokhtari, Sally...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S282-S283 , 2024
 
?
2

A Day 14 Endpoint for Acute GVHD Clinical Trials:

Spyrou, Nikolaos ; Akahoshi, Yu ; Kowalyk, Steven...
Transplantation and Cellular Therapy.  30 (2024)  4 - p. 421-432 , 2024
 
?
 
?
 
?
9

Eculizumab Treatment Outcomes in Patients with Allogeneic H..:

Samara, Yazeed ; Yao, Janny ; Tsai, Ni-Chun...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S136-S137 , 2024
 
?
11

Sirolimus Is an Acceptable Alternative to Tacrolimus for Gr..:

Elmariah, Hany ; Otoukesh, Salman ; Kumar, Ambuj...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. 229.e1-229.e11 , 2024
 
?
12

TSC-100 and TSC-101, TCR-T Cell Therapies That Target Resid..:

Al Malki, Monzr M. ; Keyzner, Alla ; Suh, Hyung C....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S1-S2 , 2024
 
?
13

Outcomes of Patients with Acute Myeloid Leukemia Undergoing..:

Blackmon, Amanda ; Afkhami, Michelle ; Al Malki, Monzr M....
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S116-S117 , 2023
 
?
14

Myeloablative Vs Reduced-Intensity Allogeneic Hematopoietic..:

Othman, Tamer ; Koller, Paul ; Tsai, Ni-Chun...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S106-S107 , 2023
 
1-15